Type 2 diabetes mellitus and renal impairment in a large outpatient electronic medical records database: Rates of diagnosis and antihyperglycemic medication dose adjustment

Postgraduate Medicine

Volumn 123, Issue 3, 2011, Pages 133-143

  Meyers, Juliana L ^a   Candrilli, Sean D ^a   Kovacs, Birgit ^b  

^a RTI HEALTH SOLUTIONS   (United States)

^b BOEHRINGER INGELHEIM PHARMACEUTICALS INC   (United States)

Author keywords

Diabetes; Electronic medical record database; Renal impairment

Indexed keywords

ALPHA GLUCOSIDASE INHIBITOR; ANTIDIABETIC AGENT; BIGUANIDE DERIVATIVE; CREATININE; DIPEPTIDYL PEPTIDASE IV; GLITAZONE DERIVATIVE; GLUCAGON LIKE PEPTIDE 1; INSULIN; MEGLITINIDE; METFORMIN; SITAGLIPTIN; SULFONYLUREA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REGIMEN; DRUG RESPONSE; ELECTRONIC MEDICAL RECORD; EVIDENCE BASED MEDICINE; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; OUTPATIENT; PRACTICE GUIDELINE; PREDICTION; REFERENCE DATABASE;

EID: 79958745412     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2011.05.2291     Document Type: Article

References (27)

1. American Heart Association. Heart Disease and Stroke Statistics-2008 Update. Dallas, TX: American Heart Association; 2008.
2. American Diabetes Association. Standards of medical care in diabetes-2009. Diabetes Care. 2009;32(suppl 1):S13-S61.
3. Rodbard HW, Blonde L, Braithwaite SS, et al; AACE Diabetes Mellitus Clinical Practice Guidelines Task Force. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract. 2007;13(suppl 1):1-68.
4. Nathan DM, Buse JB, Davidson MB, et al; American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32(1):193-203.
5. Koro CE, Lee BH, Bowlin SJ. Antidiabetic medication use and prevalence of chronic kidney disease among patients with type 2 diabetes mellitus in the United States. Clin Ther. 2009;31(11):2608-2617.
6. Levey AS, Bosch JP, Lewis JB, Green T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130(6):461-470.
7. Joint Specialty Committee on Renal Disease. Chronic kidney disease in adults: UK guidelines for identification, management and referral. June 2005.
8. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes and Prediabetes in the United States, 2011. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2008.
9. Laliberte F, Bookhart BK, Vekeman F, et al. Direct all-cause health care costs associated with chronic kidney disease in patients with diabetes and hypertension: a managed care perspective. J Manag Care Pharm. 2009;15(4):312-322.
10. Xue JL, Ma JZ, Louis TA, Collins AJ. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol. 2001;12:2753-2758.
11. Tzamaloukas AH, Murata GH. Prevention of nephropathy in patients with type 2 diabetes mellitus. Int Urol Nephrol. 2005;37(3):655-663.
12. Gaede P, Vedel P, Parving HH, Pedersen O. Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Sten type 2 randomised study. Lancet. 1999;353(9153): 617-622.
13. Kidney Disease Outcomes Quality Initiative. KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. Am J Kidney Dis. 2007;49(2 suppl 2): S12-S154.
14. Alexander GC, Sehgal NL, Moloney RM, Stafford RS. National trends in treatment of type 2 diabetes mellitus, 1994-2007. Arch Intern Med. 2008;168(10):2088-2094.
15. National Kidney Foundation. 5 Stages of chronic kidney disease. http://www.kidney.org/kidneydisease/ckd/knowGFR.cfm#chart. Accessed September 2010.
16. Charlson ME, Pompei P, Ales KL, McKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
17. Januvia (sitagliptin) [package insert]. Whitehouse Station, NJ: Merck and Co, Inc; 2007.
18. Glucophage (metformin) [package insert]. Princeton, NJ: Bristol-Myers Squibb Co; 2009.
19. Crawford AG, Cote C, Couto J, et al. Prevalence of obesity, type 2 diabetes mellitus, hyperlipidemia, and hypertension in the United States: findings from the GE Centricity electronic medical record database. Popul Health Manag. 2010;13(3):151-161.
20. Crosson JC, Ohman-Strickland PA, Hahn KA, et al. Electronic medical records and diabetes quality of care: results from a sample of family medicine practices. Ann Fam Med. 2007;5(3):209-215.
21. Feldstein AC, Nichols GA, Smith DH, Rosales AG, Perrin N. Weight change and glycemic control after diagnosis of type 2 diabetes. J Gen Intern Med. 2008;23(9):1339-1345.
22. Dalrymple LS, Katz R, Kestenbaum B, et al. Chronic kidney disease and the risk of end-stage renal disease versus death. J Gen Intern Med. 2011;26(4):379-385.
23. Krop JS, Coresh J, Chambless LE, et al. A community-based study of explanatory factors for the excess risk for early renal function decline in blacks vs white with diabetes. Arch Intern Med. 1999;159(15):1777-1783.
24. Minutolo R, De Nicola L, Mazzaglia G, et al. Detection and awareness of moderate to advanced CKD by primary care practitioners: a crosssectional study from Italy. Am J Kidney Dis. 2010;52(3):444-453.
25. Gan SC, Barr J, Arieff AI, Pearl RG. Biguanide-associated lactic acidosis. Case report and review of the literature. Arch Intern Med.1992;152(11):2333-2336.
26. Horlen C, Maline R, Bruant B, Dennis B, Carey T. Frequency of inappropriate metformin prescriptions. JAMA. 2002;287(19): 2504-2505.
27. Abarca J, Colon LR, Wang VS, Malone DC, Murphy JE, Armstrong EP. Evaluation of the performance of drug-drug interaction screening software in community and hospital pharmacies. J Manag Care Pharm. 2006;12(5):383-389.